Revance Therapeutics Inc Takeover accepted line

Sell:272.45pBuy:272.45pNo change

Prices delayed by at least 15 minutes
Sell:272.45p
Buy:272.45p
Change:No change
Prices delayed by at least 15 minutes
Sell:272.45p
Buy:272.45p
Change:No change
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
18 November 2024
David HollanderOther Level A
Sell
Tax related
3,908$4.17$16,296.36104,945
16 April 2024
Erica JordanChief Legal/Compliance Officer
Sell
Tax related
2,392$3.80$9,096.30114,864
18 March 2024
Tobin SchilkeCFO
Sell
Tax related
9,361$5.04$47,203.78192,666
18 March 2024
Dustin S SjutsPresident
Sell
Tax related
9,211$5.04$46,446.47167,550
18 March 2024
Dwight MoxieCompany Secretary
Sell
Tax related
8,125$5.04$40,971.13137,815
15 March 2024
Mark J FoleyCEO
Sell
Tax related
3,305$5.31$17,533.031,012,163
15 March 2024
Mark J FoleyCEO
Sell
Tax related
17,228$5.31$91,394.54994,935
15 March 2024
Tobin SchilkeCFO
Sell
Tax related
3,822$5.31$20,275.71202,027
15 March 2024
Dustin S SjutsPresident
Sell
Tax related
2,967$5.31$15,739.94176,761
15 March 2024
Dwight MoxieCompany Secretary
Sell
Tax related
3,269$5.31$17,342.05145,940

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
6 March 2024
Mark J FoleyCEO
Buy
Regular purchase transaction
30,000$6.98$209,400.001,015,468
15 March 2024
Mark J FoleyCEO
Sell
Tax related
17,228$5.31$91,394.54994,935
18 March 2024
Tobin SchilkeCFO
Sell
Tax related
9,361$5.04$47,203.78192,666
18 March 2024
Dustin S SjutsPresident
Sell
Tax related
9,211$5.04$46,446.47167,550
18 March 2024
Dwight MoxieCompany Secretary
Sell
Tax related
8,125$5.04$40,971.13137,815

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.